SCHEMBL6948269

SCHEMBL6948269

C#Cc1ccc(Nc2c(C(=O)O)cc(Br)c(F)c2F)c(C)c1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
MAPK1 P28482 1/20 0.45
MAP2K1 Q02750 11/20 0.39
GFER P55789 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAP2K2 P36507 3/20 0.37
CLCN2 P51788 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
TAS2R14 Q9NYV8 1/20 0.34
IDO1 P14902 1/20 0.33
AURKA O14965 1/20 0.33
TNFRSF1A P19438 1/20 0.33
KDR P35968 1/20 0.33
MAP3K9 P80192 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6946674 0.90 MAP2K1 (0.42) MEN1KMT2AMAPK1MAP2K1GFER
SCHEMBL6944532 0.88 MEN1 (0.47) MEN1KMT2AMAPK1MAP2K1GFER
SCHEMBL6944105 0.86 MAP2K1 (0.47) MEN1KMT2AMAPK1MAP2K1MAP2K2
SCHEMBL6946588 0.83 MAP2K1 (0.55) MEN1KMT2AMAPK1MAP2K1GFER
SCHEMBL2387610 0.82 MAP2K1 (0.53) MEN1KMT2AMAPK1MAP2K1GFER
SCHEMBL13841944 0.80 MEN1 (0.60) MEN1KMT2AMAPK1MAP2K1TDP1
SCHEMBL6946807 0.80 KMT2A (0.46) MEN1KMT2AMAPK1MAP2K1GFER
SCHEMBL6946598 0.80 MEN1 (0.62) MEN1KMT2AMAP2K1MAP2K2TDP1
SCHEMBL6950416 0.79 MEN1 (0.47) MEN1KMT2AMAPK1MAP2K1GFER
SCHEMBL6946682 0.79 AURKA (0.47) MEN1KMT2AMAPK1MAP2K1GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP claimed
JP-2003504401-A 2003-02-04 JP claimed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP claimed
EP-1150950-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-07 EP claimed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO claimed
WO-2000041505-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2000-07-20 WO claimed
EP-1202724-B1 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER LAMBERT CO (US) 2003-10-01 EP disclosed
EP-1202724-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2002-05-08 EP disclosed
EP-1150950-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2001-11-07 EP disclosed
WO-2001005393-A2 METHOD FOR TREATING CHRONIC PAIN USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2001-01-25 WO disclosed
WO-2000041505-A2 ANTHRANILIC ACID DERIVATIVES WARNER-LAMBERT COMPANY (US) 2000-07-20 WO disclosed